| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |